Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered
In the first months of 2023, state-level psychedelics policy reform has been so constant that it is hard to view it as a passing trend. While the first reported legalization proposal was a pre-filed measure in New York, many states have then followed suit. The list is current as of March 13.
Oklahoma, Washington and Hawaii saw their bills approved by one chamber and moving on to the other.
Proposals in Nevada, Texas, California, Missouri, New Mexico, Rhode Island, Maryland, Vermont, Minnesota, Connecticut, Illinois, Iowa, Massachusetts, Arizona, West Virginia, New York, New Hampshire, Utah and Virginia are still moving through committees.
Learn more on the bills plus reform policies passed at a local level in two other states HERE.
Ketamine-Assisted Therapy Space Sees Changes
On the heels of new telehealth regulations, including ketamine therapy, several in-clinic treatment centers are closing their operations.
One of them is Field Trip Health & Wellness Ltd. (OTC: FTHWF). In an effort to “reduce expenditures and preserve capital,” it will close its facilities in Chicago, Washington DC, Seattle, San Diego and Fredericton, Canada as of April 15.
The other is Delic Holdings (OTC: DELCF), which acquired Ketamine Wellness Centers (KWC), and “suspended” operations. While providing their patients the chance to obtain their records, no further public information was made available.
Learn more about the closings HERE.
Furthermore, major ketamine clinics chain owner Irwin Naturals Inc. (OTC: IWINF) has terminated an agreement to buy medical research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF).
Meanwhile, New York-based ketamine therapy center Nushama has exclusively shared …
